Daren M Beam
Overview
Explore the profile of Daren M Beam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
345
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonsalves C, Gibson C, Stortecky S, Alvarez R, Beam D, Horowitz J, et al.
Am Heart J
. 2023 Sep;
266:128-137.
PMID: 37703948
Background: The identification of hemodynamically stable pulmonary embolism (PE) patients who may benefit from advanced treatment beyond anticoagulation is unclear. However, when intervention is deemed necessary by the PE patient's...
2.
Howell C, Walroth T, Beam D, Geik C, Howell M, Macik M, et al.
J Pharm Pract
. 2022 Apr;
35(2):212-217.
PMID: 35484867
Venous thromboembolism (VTE) is a common medical condition often treated with direct oral anticoagulants (DOACs). Current literature supports outpatient treatment of select, low-risk VTE patients by a pharmacist with DOACs;...
3.
Stewart L, Beam D, Casciani T, Cameron S, Kline J
Int J Cardiol
. 2020 Jan;
302:138-142.
PMID: 31948673
Background: Metabolic syndrome (MetS) has been associated with a procoagulant and hypofibrinolytic state. Current data exploring the role of MetS in venous thromboembolism (VTE) are limited. The objective was to...
4.
Beam D, Brown J, Kaji A, Lagina A, Levy P, Maher P, et al.
Ann Emerg Med
. 2019 Nov;
75(3):400-407.
PMID: 31668572
No abstract available.
5.
DiRenzo B, Beam D, Kline J, Deodhar K, Weber Z, Davis C, et al.
Acad Emerg Med
. 2017 Sep;
25(6):634-640.
PMID: 28921763
Objective: The objective was to describe the implementation, work flow, and differences in outcomes between a pharmacist-managed clinic for the outpatient treatment of venous thromboembolism (VTE) using a non-vitamin K...
6.
Kline J, Kahler Z, Beam D
Patient Prefer Adherence
. 2016 May;
10:561-9.
PMID: 27143861
Background: Oral monotherapy anticoagulation has facilitated home treatment of venous thromboembolism (VTE) in outpatients. Objectives: The aim of this study was to measure efficacy, safety, as well as patient and...
7.
Beam D, Kahler Z, Kline J
Acad Emerg Med
. 2015 Jun;
22(7):788-95.
PMID: 26113241
Objectives: The study hypothesis was that a target-specific anticoagulant would allow successful home treatment of selected patients with deep vein thrombosis (DVT) and pulmonary embolism (PE) diagnosed in two urban...
8.
Kahler Z, Beam D, Kline J
Acad Emerg Med
. 2015 Jun;
22(7):796-802.
PMID: 26111453
Background: Target-specific anticoagulants such as rivaroxaban facilitate immediate discharge of low-risk venous thromboembolism (VTE; including deep vein thrombosis [DVT] and pulmonary embolism [PE]) allowing treatment at home instead of hospitalization....
9.
Russell F, Moore C, Courtney D, Kabrhel C, Smithline H, Nordenholz K, et al.
Am J Emerg Med
. 2015 Mar;
33(4):542-7.
PMID: 25769797
Background: Many patients have unexplained persistent dyspnea after negative computed tomographic pulmonary angiography (CTPA). We hypothesized that many of these patients have isolated right ventricular (RV) dysfunction from treatable causes....
10.
Beam D, Neto-Neves E, Stubblefield W, Alves N, Tune J, Kline J
Comp Med
. 2015 Mar;
65(1):54-61.
PMID: 25730758
Pulmonary embolism (PE) is a leading cause of sudden cardiac death, and a model is needed for testing potential treatments. In developing a model, we compared the hemodynamic effects of...